Grazax®, a grass-pollen allergen tablet, has been launched for use in children and adolescents aged 5 to 17 by Allergy Company ALK-AbellĂ³. Grazax is the only non-injection immunotherapy licensed to treat children suffering from severe hay fever caused by grass pollen allergy. Grazax has been available for use in adults in the UK since January 2007. It's a once daily, fast-melting tablet which is placed under the tongue. Read more ...
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment